Sonoma Pharmaceuticals files prospectus supplement for existing ATM equity offering with Maxim Group

Sonoma Pharmaceuticals, Inc.

Company entered Equity Distribution Agreement with Maxim Group on Dec 15, 2023, amended March 8, 2024.
Prospectus supplement filed Sept 20, 2024 under effective S-3 registration statement (File No. 333-275311).
Shares sold under ATM via Maxim as sales agent; no specific number or amount disclosed in filing.
Polsinelli PC opinion on validity of shares filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.